"STATINS KALEIDOSCOPE". MYOPATHY FROM STATINS
Keywords:
Myopathy, Statins, IMNM, HMGCR, Patients, Albania, etc.Abstract
Statins are medications that inhibit the 3-hydroxy-3-methylglutaryl-CoA reductase enzyme, thus inhibiting cholesterol biosynthesis. Statins reduce cardiovascular risk and morbidity in patients with coronaropathia, however, without forgetting their side effect in muscle toxicity. Clinically, patients with myopathy caused by statins are divided into four main groups: those with rhabdomyolysis, myalgia / hyper CPK, toxic myopathy limited by statins and myositis (necrotizing myopathy mediated by immune complexes with anti-HMGCR antibodies, IMNM).
References
Gotto AM, Jr. Safety and statin therapy: Reconsidering the risks and benefits. Arch Intern Med 2003; 163: 657-659.
Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 2001; 35 (9): 1096-1107.
Merck Sharp & Dohme (New Zealand) Limited. Lipex Data Sheet February 2003. www.medsafe.govt.nz/Profs/Datasheet/l/Lipextab.htm
Pfizer Laboratories Limited. Lipitor Data Sheet 30 September 2003. www.medsafe.govt.nz/profs/Datasheet/l/Lipitortab.htm
Australian Adverse Drug Reaction Advisory Committee (ADRAC). Risk factors for myopathy and rhabdomyolysis with the statins. Aust Adverse Drug React Bull 2004; 23 (1): 2.
